scispace - formally typeset
E

Elias Perentes

Researcher at Novartis

Publications -  40
Citations -  2796

Elias Perentes is an academic researcher from Novartis. The author has contributed to research in topics: Kidney & Glial fibrillary acidic protein. The author has an hindex of 19, co-authored 40 publications receiving 2627 citations. Previous affiliations of Elias Perentes include University of Basel.

Papers
More filters
Journal ArticleDOI

Protein Kinase Bα/Akt1 Regulates Placental Development and Fetal Growth

TL;DR: It is shown that PKBα is widely expressed in placenta including all types of trophoblast and vascular endothelial cells and shows significant hypotrophy, with marked reduction of the decidual basalis and nearly complete loss of glycogen-containing cells in the spongiotrophoblast, and exhibit decreased vascularization.
Journal ArticleDOI

Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury

TL;DR: Gene and protein expression analysis, in-situ hybridization and immunohistochemistry provide mechanistic evidence to support the use of four previously described nephrotoxicity markers for detecting kidney injury to guide regulatory decision making in drug development.
Journal ArticleDOI

Class III β-tubulin isotype: A key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology

TL;DR: Because class III β-tubulin is present in neoplastic but not in normal differentiated glial cells, the elucidation of molecular mechanisms responsible for the altered expression of this isotype may provide critical insights into the dynamics of the microtubule cytoskeleton in the growth and progression of gliomas.
Journal ArticleDOI

Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material.

TL;DR: Increased immunoreactivity for Ki-67 epitopes (Ki-67 LI higher than 4) was noted in a number of meningiomas, astrocytomas, ependymomas, oligodendrogliomas and paragangliomas, contrasting with their benign histological features.